secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0000950170-25-101103
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulgent Q2 core revenue $81.7M (+16% YoY); raises FY2025 guidance to $320M
--------------------------------------------------------------------------

- Core revenue $81.7M, up 16% YoY; total revenue $81.8M.
- GAAP net loss $19.0M ($0.62 per share) includes one-time charge; non-GAAP net income $2.1M ($0.07 per share).
- Adjusted EBITDA loss of $3.0M.
- Raising full-year 2025 core revenue guidance to $320M.
- Cash and investments $777.5M at June 30; repurchased ~130k shares for $2.2M in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000095017025101103/0000950170-25-101103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000095017025101103/flgt-20250801.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-101103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer